Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study

Authors :: Madeddu, G
Soddu, V
Ricci, E
Quirino, T
Menzaghi, B
Bellacosa, C
Grosso, C
Melzi, S
Valsecchi, L
Franzetti, M
Vichi, F
Penco, G
Di Biagbio, A
Pellicanò, G
Corsico, L
De Socio, Gvl
Mazzotta, E
Parruti, G
Guastavigna, M
Orofino, G
Mura, Ms
Bonfanti, P
Source :: Journal of the International AIDS Society. November, 2010, Vol. 13, p111, 1 p.
Publication Year :: 2010
Abstract: 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK<br />Purpose of the study To further investigate CPK increases and muscle symptoms in a cohort of HIV‐infected patients receiving raltegravir‐based HAART compared with a control cohort with similar characteristics receiving [...]

Subjects :: Creatine kinase -- Measurement -- Health aspects
Raltegravir -- Complications and side effects -- Physiological aspects
Muscles -- Health aspects
Health

Full Text Access

Tools